VolitionRX Limited (VNRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 1489 WEST WARM SPRINGS ROAD
HENDERSON, NV 89014
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,86720,58119,44516,96613,42710,116
Cash and cash equivalents10,86720,58119,44516,96613,42710,116
Receivables73137   
Prepaid expense785598303268245249
Other current assets448787577323230202
Total current assets:12,17221,97920,33217,55613,90210,567
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization    (41)
Operating lease, right-of-use asset619384326381
Property, plant and equipment5,3934,9115,1712,9813,1203,481
Intangible assets, net (including goodwill)111217322372467576
Intangible assets, net (excluding goodwill)111217322372467576
Other undisclosed noncurrent assets    41  
Total noncurrent assets:6,1235,5125,8193,7353,5874,057
TOTAL ASSETS:18,29527,49026,15121,29117,48914,624
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,9155,3835,0312,7961,7301,630
Accounts payable3,0431,5421,540627807352
Accrued liabilities2,8723,8413,4922,1699231,278
Deferred revenue10,000   
Debt1,1137981,0811,003417444
Other undisclosed current liabilities35833512461186216
Total current liabilities:17,3866,5166,2373,8602,3332,290
Noncurrent Liabilities
Long-term debt and lease obligation3,2152,7823,3612,9351,9841,313
Long-term debt, excluding current maturities2,7792,2712,6072,1951,9841,313
Finance lease, liability436511602608
Liabilities, other than long-term debt400     
Operating lease, liability400 152132
Other undisclosed noncurrent liabilities4204712602981,0311,063
Total noncurrent liabilities:4,0363,2523,6203,2333,0152,376
Total liabilities:21,4229,7689,8577,0935,3494,667
Equity
Equity, attributable to parent, including:(3,127)17,72216,29414,19912,1409,958
Common stock585449413527
Additional paid in capital164,397154,731126,526103,85485,60465,775
Accumulated other comprehensive income (loss)227148(60)126224(129)
Accumulated deficit(167,257)(136,989)(110,174)(89,822)(73,723)(55,714)
Other undisclosed equity, attributable to parent (552)(222)(47)   
Equity, attributable to noncontrolling interest (222)    
Other undisclosed equity  22247   
Total equity:(3,127)17,72216,34114,19912,1409,958
Other undisclosed liabilities and equity   (47)   
TOTAL LIABILITIES AND EQUITY:18,29527,49026,15121,29117,48914,624

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues306901317 350
Loss on disposition of assets for financial service operations  (26)   
Other income1,182    350
Cost of revenue
(Cost of Goods and Services Sold)
   (800)   
Gross profit:30690(787)17 350
Operating expenses(32,086)(28,423)(21,261)(16,060)(17,898)(15,046)
Other undisclosed operating income (loss)   800  (350)
Operating loss:(31,780)(28,333)(21,248)(16,043)(17,898)(15,046)
Nonoperating income (expense) 1,343849(56)  
Other nonoperating income    197  
Interest and debt expense(173)(156)(130)127(111)(73)
Loss from continuing operations before income taxes:(31,953)(27,146)(20,529)(15,972)(18,009)(15,119)
Other undisclosed income from continuing operations  331177   
Loss from continuing operations:(31,953)(26,815)(20,352)(15,972)(18,009)(15,119)
Loss before gain (loss) on sale of properties:(26,815)(20,352)(15,972)(18,009)(15,119)
Other undisclosed net income (loss) (175) (127)  
Net loss:(31,953)(26,990)(20,352)(16,099)(18,009)(15,119)
Net income attributable to noncontrolling interest      
Other undisclosed net income (loss) attributable to parent1,355 (47)  350
Net loss available to common stockholders, diluted:(30,598)(26,990)(20,399)(16,099)(18,009)(14,769)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(31,953)(26,990)(20,352)(16,099)(18,009)(15,119)
Other comprehensive income (loss)  (26,781)(20,585)(16,197) 64
Other undisclosed comprehensive income      
Comprehensive loss:(31,953)(53,771)(40,937)(32,296)(18,009)(15,055)
Comprehensive income, net of tax, attributable to noncontrolling interest      
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    353350
Comprehensive loss, net of tax, attributable to parent:(31,953)(53,771)(40,937)(32,296)(17,656)(14,705)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: